Altering certain molecular interactions could yield new strategies for treating prostate cancer
Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San ...
Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San ...
In a recent article published in Molecular Psychiatry, researchers performed longitudinal studies in rats to measure the sensitivity of early established ...
In a recent study published in Nature Biomedical Engineering, researchers used an interdisciplinary approach incorporating phylogenetics, 3D protein modeling, and ...
In a recent study published in Neuron, researchers explored the biological mechanisms by which exercise-induced irisin attenuates amyloid-beta (Aβ) pathology ...
In a recent preprint posted to the bioRxiv* server, researchers characterized two novel XBB variants, EG.5.1 and XBB.2.3, with the former ...
For roughly 80% of breast cancer survivors, treatment doesn't end with surgery, radiation and chemotherapy. Instead, for the next five ...
Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor ...
According to new research in the journal Immunity, T cells have a nuclear receptor doing something very odd-;but very important-;to ...
Pelvic pain in women with endometriosis is attributed to neuroinflammation. Researchers investigated biochemical mediators of endometriosis-associated pelvic pain to provide ...
Dementia is defined as the loss of cognitive functioning-;including thinking, remembering, and reasoning-; and is very prevalent in Japan. Currently, ...
Noted experts in cardiovascular rehabilitation attending the Third Jim Pattison-Mazankowski Alberta Heart Institute Cardiac Rehabilitation Symposium (Banff, April 21-23, 2023)...
Read moreNEWS RELEASE: Dinsmore Earns Distinction as HP Digital Manufacturing Partner Dinsmore EVP Jay Dinsmore (left) and Greg Elfering, Head of...
Read moreScientists have developed a potentially transformative new technique that could aid in the discovery and development of new therapeutics for...
Read moreMedtronic SVP and President of Coronary and Renal Denervation Jason Weidman It took Medtronic nearly 13 years to win FDA...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.